Update on Bluebird Bio’s Gene Therapy Trial – Rare Disease Report
|
Update on Bluebird Bio's Gene Therapy Trial
Rare Disease Report Marina Cavazzana, MD, PhD, of the Hôpital Universitaire Necker-Enfants Malades, Paris, France discusses the latest data on bluebird bio's gene therapy to treat β-thalassemia and sickle cell disease. Patients in this phase 1/2 study were given one … |
